Thromboembolic risk of tamoxifen in patients with stage II breast cancer. [electronic resource]
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct 1989
- 1579-80 p. digital
Publication Type: Comment; Letter
0732-183X
10.1200/JCO.1989.7.10.1579 doi
Age Factors Breast Neoplasms--drug therapy Female Humans Neoplasm Staging Tamoxifen--adverse effects Thromboembolism--chemically induced